Searched for
AUROBINDO PHARMA NEWS
Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...- Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...
- Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities rallied sharply as an interim US-Iran peace framework eased geopolitical concerns and pushed oil prices lower. Improved inf...
- Flexi cap fund inflows halve to Rs 5,175 crore in May after record April. Is this profit booking or a buying opportunity?Flexi cap fund inflows dropped 49% in May to Rs 5,175 crore after April’s record surge, reflecting broader moderation across equity categor...
- Stocks in news: Rajesh Exports, Lenskart, Suzlon Energy, Aurobindo Pharma, Tata MotorsIndian markets saw volatility and closed lower on Wednesday. Key companies are in focus due to significant developments. SoftBank reduced i...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Quant Mid Cap Fund exits Lenskart Solutions and 2 other stocks, adds SAIL in AprilQuant Mid Cap Fund exited Lenskart Solutions, NMDC and SBI Cards in April, while adding Steel Authority of India to its portfolio, the fund...
- Another buyback offer coming soon! This time it's from Bajaj AutoBajaj Auto has announced that its board will consider a share buyback proposal on May 6, 2026, signalling plans to return surplus cash to s...
- Stocks in news: SBI Life, Trent, Tata Investment, HCL Tech, Suzlon EnergyIn today's trade, shares of SBI Life, Trent, Tata Investment, HCL Tech, Suzlon Energy among others will be in focus due to various news dev...
- Aurobindo Pharma announces schedule, record date for its Rs 800 crore share buybackAurobindo Pharma has announced an Rs 800 crore share buyback via the tender route, offering Rs 1,475 per share. The buyback opens April 23 ...
- Buyback alert! Last date to buy Aurobindo Pharma shares for Rs 800-crore share buyback. Check detailsAurobindo Pharma has announced an ₹800-crore buyback at ₹1,475 per share, with April 17, 2026 set as the record date—meaning investors must...
- Share buybacks this month: Wipro, Aurobindo Pharma, 2 other stocks to watch out forFour companies—Wipro, Cyient, Windlas Biotech, and Aurobindo Pharma—are set to announce or act on share buybacks this month, with Aurobindo...
- Aurobindo Pharma share buyback, Muthoot Fin dividend, 2 other corporate actions next weekAurobindo Pharma’s share buyback and Muthoot Finance’s dividend announcement headline a set of four key corporate actions lined up for the ...
- Aurobindo Pharma's Eugia Unit-3 gets warning letter from USFDA, shares fallAurobindo Pharma's subsidiary Eugia Pharma Specialities received a warning letter from the USFDA concerning its formulations manufacturing ...
- Aurobindo Pharma tumbles 4%, hits 52-week low as USFDA issues 6 observationsFollowing the development, Aurobindo Pharma’s counter touched a 52-week low of Rs 581 on the BSE. The scrip had closed at Rs 603.05 on Tues...
- Valuations of Aurobindo Pharma cheaper than many frontline peers; further upside likely: Anand TondonTondon said that he would not be surprised if the stock rallies further. He expects the US FDA clearance to make sure that earnings meet ex...
- Sell call on Aurobindo Pharma: Gaurang Shah, Geojit BNP Paribas Financial ServicesWe had a positive coverage on Aurobindo Pharma. Post this news we need to go back to our working table and have a re-look on our stance ove...
- Aurobindo Pharma is into a downtrend: CK Narayan"Aurobindo Pharma has been smashed a bit on news. The news is old or new but then the fact remains that the market has actually chosen to h...
- Aurobindo Pharma good buy among pharma stocks: Ashwani GujralAurobindo Pharma corrected fairly sharply on the news, and Rs 155-160 is now a good base for Aurobindo Pharma. On the upside, it will face ...
Load More
